Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||37.31 x 100|
|Ask||55.00 x 300|
|Day's Range||37.30 - 37.89|
|52 Week Range||20.68 - 40.83|
|PE Ratio (TTM)||-14.84|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
Billionaire superinvestors Felix and Julian Baker started buying shares of the beaten-down vaccine maker Novavax in the second quarter.
Supernus (SUPN) decides to stop evaluating the lower dose option of SPN-810 for treatment of impulsive aggression. However, the company will carry on with the study of higher dose arm or placebo.